Lumacyte CEO on how real-time insight is driving down manufacturing failures and opening doors for more patients.
CHICAGO and FORT WORTH, Texas, June 20, 2025 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company focused on developing ...
The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback